414 related articles for article (PubMed ID: 20110413)
21. Pharmacogenomic Variants May Influence the Urinary Excretion of Novel Kidney Injury Biomarkers in Patients Receiving Cisplatin.
Chang C; Hu Y; Hogan SL; Mercke N; Gomez M; O'Bryant C; Bowles DW; George B; Wen X; Aleksunes LM; Joy MS
Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28640195
[TBL] [Abstract][Full Text] [Related]
22. Role of the copper transporter, CTR1, in platinum-induced ototoxicity.
More SS; Akil O; Ianculescu AG; Geier EG; Lustig LR; Giacomini KM
J Neurosci; 2010 Jul; 30(28):9500-9. PubMed ID: 20631178
[TBL] [Abstract][Full Text] [Related]
23. Evaluating protective and therapeutic effects of alpha-lipoic acid on cisplatin-induced ototoxicity.
Kim KH; Lee B; Kim YR; Kim MA; Ryu N; Jung DJ; Kim UK; Baek JI; Lee KY
Cell Death Dis; 2018 Aug; 9(8):827. PubMed ID: 30068942
[TBL] [Abstract][Full Text] [Related]
24. Susceptibility of mouse cochlear hair cells to cisplatin ototoxicity largely depends on sensory mechanoelectrical transduction channels both Ex Vivo and In Vivo.
Maruyama A; Kawashima Y; Fukunaga Y; Makabe A; Nishio A; Tsutsumi T
Hear Res; 2024 Jun; 447():109013. PubMed ID: 38718672
[TBL] [Abstract][Full Text] [Related]
25. Organic Cation Transporter 2 Overexpression May Confer an Increased Risk of Gentamicin-Induced Nephrotoxicity.
Gai Z; Visentin M; Hiller C; Krajnc E; Li T; Zhen J; Kullak-Ublick GA
Antimicrob Agents Chemother; 2016 Sep; 60(9):5573-80. PubMed ID: 27401566
[TBL] [Abstract][Full Text] [Related]
26. Protective effect of concomitant administration of imatinib on cisplatin-induced nephrotoxicity focusing on renal organic cation transporter OCT2.
Tanihara Y; Masuda S; Katsura T; Inui K
Biochem Pharmacol; 2009 Nov; 78(9):1263-71. PubMed ID: 19540211
[TBL] [Abstract][Full Text] [Related]
27. Modulating the Activity of the Human Organic Cation Transporter 2 Emerges as a Potential Strategy to Mitigate Unwanted Toxicities Associated with Cisplatin Chemotherapy.
Hucke A; Kantauskaite M; Köpp TN; Wehe CA; Karst U; Nedvetsky PI; Ciarimboli G
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474165
[TBL] [Abstract][Full Text] [Related]
28. Proximal tubular secretion of creatinine by organic cation transporter OCT2 in cancer patients.
Ciarimboli G; Lancaster CS; Schlatter E; Franke RM; Sprowl JA; Pavenstädt H; Massmann V; Guckel D; Mathijssen RH; Yang W; Pui CH; Relling MV; Herrmann E; Sparreboom A
Clin Cancer Res; 2012 Feb; 18(4):1101-8. PubMed ID: 22223530
[TBL] [Abstract][Full Text] [Related]
29. Cisplatin nephrotoxicity: a review of the literature.
Manohar S; Leung N
J Nephrol; 2018 Feb; 31(1):15-25. PubMed ID: 28382507
[TBL] [Abstract][Full Text] [Related]
30. Differential contribution of organic cation transporters, OCT2 and MATE1, in platinum agent-induced nephrotoxicity.
Yokoo S; Yonezawa A; Masuda S; Fukatsu A; Katsura T; Inui K
Biochem Pharmacol; 2007 Aug; 74(3):477-87. PubMed ID: 17582384
[TBL] [Abstract][Full Text] [Related]
31. Differential transport of platinum compounds by the human organic cation transporter hOCT2 (hSLC22A2).
Burger H; Zoumaro-Djayoon A; Boersma AW; Helleman J; Berns EM; Mathijssen RH; Loos WJ; Wiemer EA
Br J Pharmacol; 2010 Feb; 159(4):898-908. PubMed ID: 20067471
[TBL] [Abstract][Full Text] [Related]
32. Cisplatin ototoxicity in rat cochlear organotypic cultures.
Ding D; He J; Allman BL; Yu D; Jiang H; Seigel GM; Salvi RJ
Hear Res; 2011 Dec; 282(1-2):196-203. PubMed ID: 21854840
[TBL] [Abstract][Full Text] [Related]
33. Renoprotective mechanisms of chlorogenic acid in cisplatin-induced kidney injury.
Domitrović R; Cvijanović O; Šušnić V; Katalinić N
Toxicology; 2014 Oct; 324():98-107. PubMed ID: 25043994
[TBL] [Abstract][Full Text] [Related]
34. Effect of lycopene against cisplatin-induced acute renal injury in rats: organic anion and cation transporters evaluation.
Erman F; Tuzcu M; Orhan C; Sahin N; Sahin K
Biol Trace Elem Res; 2014 Apr; 158(1):90-5. PubMed ID: 24531880
[TBL] [Abstract][Full Text] [Related]
35. The expression of copper transporters associated with the ototoxicity induced by platinum-based chemotherapeutic agents.
Perde-Schrepler M; Fischer-Fodor E; Virag P; Brie I; Cenariu M; Pop C; Valcan A; Gurzau E; Maniu A
Hear Res; 2020 Mar; 388():107893. PubMed ID: 32006874
[TBL] [Abstract][Full Text] [Related]
36. Comparative in vivo evaluations of curcumin and its analog difluorinated curcumin against cisplatin-induced nephrotoxicity.
Sahin K; Orhan C; Tuzcu M; Muqbil I; Sahin N; Gencoglu H; Guler O; Padhye SB; Sarkar FH; Mohammad RM
Biol Trace Elem Res; 2014 Feb; 157(2):156-63. PubMed ID: 24415068
[TBL] [Abstract][Full Text] [Related]
37. The identification of dual protective agents against cisplatin-induced oto- and nephrotoxicity using the zebrafish model.
Wertman JN; Melong N; Stoyek MR; Piccolo O; Langley S; Orr B; Steele SL; Razaghi B; Berman JN
Elife; 2020 Jul; 9():. PubMed ID: 32720645
[TBL] [Abstract][Full Text] [Related]
38. Role of Mouse Organic Cation Transporter 2 for Nephro- and Peripheral Neurotoxicity Induced by Chemotherapeutic Treatment with Cisplatin.
Hucke A; Schröter R; Ceresa C; Chiorazzi A; Canta A; Semperboni S; Marmiroli P; Cavaletti G; Gess B; Ciarimboli G
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511245
[TBL] [Abstract][Full Text] [Related]
39. Targeting Oct2 and P53: Formononetin prevents cisplatin-induced acute kidney injury.
Huang D; Wang C; Duan Y; Meng Q; Liu Z; Huo X; Sun H; Ma X; Liu K
Toxicol Appl Pharmacol; 2017 Jul; 326():15-24. PubMed ID: 28414026
[TBL] [Abstract][Full Text] [Related]
40. Organic cation transporters are determinants of oxaliplatin cytotoxicity.
Zhang S; Lovejoy KS; Shima JE; Lagpacan LL; Shu Y; Lapuk A; Chen Y; Komori T; Gray JW; Chen X; Lippard SJ; Giacomini KM
Cancer Res; 2006 Sep; 66(17):8847-57. PubMed ID: 16951202
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
